Staining Quality Assessment for HER2 Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Variability in staining quality in working laboratories leads to unreliable HER2 testing results, particularly in breast cancer assessments, due to subjective interpretation and lack of standardized quantitative measures, resulting in false-negative and false-positive test results.

Innovation Solution

A method for assessing staining quality by comparing control specimens from working laboratories with reference specimens validated through standardized protocols, using digital imaging and quantitative quality parameters like connectivity, intensity, and completeness to provide a quantitative quality measure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If subjective interpretation methods are used for staining quality assessment, then ease of operation is improved, but measurement precision deteriorates

Engineering Contradiction:
Improveease of operationVSAvoidmeasurement precision
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent replaces the mechanical/subjective visual interpretation system with an automated digital image analysis system. The system uses computer algorithms to objectively measure staining quality parameters such as intensity, uniformity, and completeness, eliminating human subjectivity while maintaining operational simplicity through automated processing of digital images.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If standardized quantitative assessment methods are implemented, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improvemeasurement precisionVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses digital copies (images) of stained specimens instead of analyzing the physical specimens directly. This allows standardized quantitative assessment to be performed on reproducible digital representations, enabling precise measurement without requiring complex physical manipulation or specialized equipment beyond standard digital imaging capabilities.

Inventive Principle:
Principle #26Copying

3Reliability

If quantitative quality parameters are calculated and correlated, then reliability is improved, but loss of time increases

Engineering Contradiction:
ImprovereliabilityVSAvoidloss of time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent implements continuous automated processing where digital images are immediately analyzed using pre-programmed algorithms to calculate quality parameters. The system continuously processes images without interruption, performing intensity measurements, uniformity assessments, and completeness evaluations in an uninterrupted sequence, thereby minimizing delays while ensuring reliable quantitative results.

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentEP3117259B1Assessment of staining quality
Publication Date: 2020.01.15 VISIOPHARM AS
  • EP3117259B1 patent drawingFigure 1~2
  • EP3117259B1 patent drawingFigure 3~4
  • EP3117259B1 patent drawingFigure 5A

AI summary

The quality of staining histological specimens has an impact on the histological assessment of the specimen. One of the causes for variability in the accuracy is the variations in the staining of the specimens to be tested in the working laboratories. The present invention provides a method for assessing the staining quality in a working laboratory and providing a quantitative quality measure for the staining quality. Thereby, it is possible for each working laboratory to evaluate their staining quality and to get feedback of how to improve the quality. The invention further relates to a system and a software program for carrying out the method.